What is the appropriate aztreonam dosing for an adult patient with renal impairment?

Aztreonam Dosing in Renal Impairment

In patients with renal impairment, aztreonam requires dose reduction based on creatinine clearance: give the full loading dose (1-2g), then halve the maintenance dose for CrCl 10-30 mL/min, or reduce to one-fourth for CrCl <10 mL/min, with supplemental dosing after hemodialysis.

Dosing Algorithm by Renal Function

The FDA-approved dosing strategy 11 provides clear guidance based on creatinine clearance:

Normal Renal Function (CrCl >30 mL/min)

• Standard dosing: 1-2g every 6-8 hours depending on infection severity
• No adjustment needed 21

Moderate Renal Impairment (CrCl 10-30 mL/min/1.73m²)

• Loading dose: Full dose (1g or 2g) initially
• Maintenance: Half the usual dose at standard intervals (every 6,8, or 12 hours)
• Example: If standard dose is 2g q8h, give 2g loading, then 1g q8h 1

Severe Renal Impairment (CrCl <10 mL/min/1.73m²)

• Loading dose: Full dose (500mg, 1g, or 2g) initially
• Maintenance: One-fourth the usual initial dose at standard intervals
• Example: If standard dose is 2g q8h, give 2g loading, then 500mg q8h 1

Hemodialysis Patients

• Give standard loading dose
• Maintenance: One-fourth usual dose at standard intervals
• Supplemental dose: Give one-eighth of the initial dose after each hemodialysis session 1
• Alternative simplified approach: 1-2g once daily after hemodialysis achieves >90% target attainment for MICs ≤4-8 mg/L 3

Pharmacokinetic Rationale

Aztreonam is primarily renally eliminated (60-70% recovered unchanged in urine), making dose adjustment critical 11. The serum half-life increases dramatically with declining renal function:

• Normal function: 1.7 hours
• Severe impairment: 6-8.4 hours 45

Total clearance correlates closely with creatinine clearance (r=0.97), with clearance dropping from 107 mL/min in normal subjects to 29 mL/min in anephric patients 4. Population pharmacokinetic modeling confirms these adjustments maintain adequate target attainment (>90% PTA) across renal function strata 6.

Estimating Creatinine Clearance

When only serum creatinine is available, use the Cockcroft-Gault equation 1:

Males: CrCl = [weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)]

Females: 0.85 × male value

Critical caveat: Serum creatinine must represent steady-state renal function 1. In elderly patients, creatinine may underestimate renal impairment—obtain formal creatinine clearance estimates 1.

Peritoneal Dialysis

For CAPD patients:

• Loading: 1g IV
• Maintenance: 0.5g intraperitoneally every 6 hours for peritonitis 7
• Serum half-life remains ~7 hours; peritoneal clearance is minimal (2.1 mL/min) 7

Key Clinical Pitfalls

1. Don't skip the loading dose: Even in severe renal impairment, give the full initial dose to achieve therapeutic levels rapidly 16

2. Hemodialysis removes significant drug: 38-58% removed during 4-hour session, necessitating post-dialysis supplementation 47

3. Elderly patients need special attention: Age-related creatinine clearance decline may not be reflected in serum creatinine—always calculate estimated clearance 1

4. For severe infections (especially Pseudomonas): Consider 2g q6-8h as initial therapy even with adjustment, then titrate based on clinical response 21